Takeda's dengue vaccine candidate shows efficacy in children aged 4 to 16, regardless of previous exposure to dengue fever – wallstreet-online

Takeda's dengue vaccine candidate shows efficacy in children aged 4 to 16, regardless of previous exposure to dengue wallstreet-online

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.